Since a schizophrenia drug, the first in decades with an innovative mechanism of action, gained US regulatory approval in September, some researchers have proclaimed a new era for psychiatric ...

Summary. Iloperidone is an atypical antipsychotic that recently received marketing approval from the Food and Drug Administration for the acute treatment of schizophrenia. Iloperidone is a pure ...

Antipsychotics commonly used in the treatment of schizophrenia target dopamine receptors ... Researchers have developed a new drug, dubbed LY2140023, which is converted to a selective agonist ...

has approved Cobenfy (xanomeline/trospium chloride), a new medication offering a novel approach to treating schizophrenia, ...

Schizophrenia is a serious mental illness that requires treatment with medication to lessen symptoms. But even if your symptoms go away, you'll need to stay on treatment to avoid a relapse.

Nov 5 (Reuters) - Intra-Cellular Therapies (ITCI.O), opens new tab said on Tuesday its drug to prevent relapses in schizophrenia patients met the main goal of a late-stage trial. Schizophrenia ...

A person has treatment-resistant schizophrenia if they try two or more schizophrenia drugs at the right dose and do not see any improvement in symptoms. A 2020 study estimates that 34% of people ...

Medically reviewed by Steven Gans, MDDisorganized schizophrenia is characterized by speech, emotional expressions, thoughts, and actions that are "disorganized" or not in tune with what is expected or ...